The incidence of advanced breast cancer diagnosis among black women remained 30 percent to 90 percent higher compared to white women between 1992 and 2004, according to new findings by researchers at Fred Hutchinson Cancer Research Center. In addition, the disparity in the incidence of advance colorectal cancer actually widened over this time period as rates fell among whites but increased
A test for early detection of colon cancer has cleared the pre-clinical hurdle and is poised to enter the regulatory process - with a potential sale in the offing. Developed by Knoxville couple Nancy Tommye Jordan and Doug Jordan, and bought by local entrepreneur Tom Boyd in 2005, the test detects a biomarker in the blood, discovered by the Jordans nearly 40 years ago, that indicates the
Major US Manufacturer Improves Employee Screening Rates for Colon Cancer with Non-Invasive DNA Test
EXACT Sciences Corporation today announced that Crown, Cork & Seal , a global consumer packaging manufacturing company with approximately 27,000 employees headquartered in Philadelphia, Pennsylvania, is now using PreGen-Plus, a proprietary non-invasive DNA testing technology for colon cancer, which is based in part upon patents owned by EXACT Sciences Corporation.
"OUR mother had suffered from an episode of high blood pressure and difficulty in breathing followed by fever during the week in between Christmas and New Year. Since that time, we became concerned because of her consistent cough, loss of appetite and noticeable weight loss."
Contact:
Copyright © 2005 Colon Cancer Solutions.com All Rights Reserved